Sermonix Pharmaceuticals, Inc.

CIK 1655566 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Sermonix Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 31, 2026SCHEDULE 13D0001655566-26-000003
Nov 23, 2021D0001655566-21-000002
Jul 11, 2016D0001655566-16-000003
Oct 14, 2015D0001655566-15-000002